Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.28B | 36.72B | 45.71B | 45.58B | 43.81B | 44.97B | Gross Profit |
6.15B | 12.26B | 14.86B | 15.01B | 13.72B | 14.29B | EBIT |
2.38B | 3.67B | 4.46B | 5.37B | 3.42B | 3.62B | EBITDA |
6.09B | 14.78B | 11.77B | 13.00B | 13.60B | 14.08B | Net Income Common Stockholders |
1.06B | 1.14B | 11.84B | 2.24B | 59.00M | -920.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.88B | 10.53B | 18.48B | 14.73B | 11.87B | 19.53B | Total Assets |
172.11B | 144.35B | 155.52B | 154.05B | 155.06B | 168.17B | Total Debt |
43.57B | 54.36B | 61.50B | 67.18B | 66.80B | 69.63B | Net Debt |
36.45B | 48.18B | 49.80B | 59.68B | 60.98B | 56.08B | Total Liabilities |
72.45B | 83.35B | 91.04B | 96.98B | 97.25B | 105.54B | Stockholders Equity |
99.65B | 59.97B | 63.40B | 54.78B | 55.80B | 61.41B |
Cash Flow | Free Cash Flow | ||||
3.46B | 9.70B | 13.10B | 13.53B | 11.80B | 12.20B | Operating Cash Flow |
5.64B | 16.56B | 18.05B | 18.08B | 17.21B | 17.38B | Investing Cash Flow |
2.47B | -6.12B | -379.00M | -6.87B | -9.26B | -8.09B | Financing Cash Flow |
-7.33B | -15.86B | -13.43B | -9.71B | -15.20B | -9.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $186.82B | 10.53 | 18.23% | 6.10% | 0.93% | 56.97% | |
76 Outperform | $118.89B | 11.52 | 36.94% | ― | 0.93% | 16.06% | |
76 Outperform | $132.32B | 8.70 | 18.57% | 3.54% | 1.33% | 7.69% | |
76 Outperform | $277.33B | 23.81 | 19.35% | 1.27% | 5.31% | 38.46% | |
71 Outperform | $24.12B | 9.21 | -7.17% | 6.70% | -24.84% | -74.77% | |
69 Neutral | $201.62B | 17.21 | 11.38% | 3.96% | 0.50% | -12.66% | |
60 Neutral | $14.06B | 6.51 | -3.76% | 3.69% | 2.48% | -35.40% |